NTRB
Nutriband Inc.
There isn't enough reported data to score NTRB yet.
NTRB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
NTRB's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
NTRB PE Valuation
NTRB has no meaningful PE right now: it lost money over the past year.
NTRB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect NTRB's losses to shrink, with revenue declining.
NTRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.90 | -$0.13 |
| Q1 2025 | -$0.99 | -$0.30 |
| Q4 2024 | -$0.71 | -$0.07 |
| Q3 2024 | -$0.81 | -$0.25 |
| Q2 2022 | -$0.84 | -$0.43 |
| Q1 2022 | -$0.80 | -$0.36 |
| Q4 2021 | -$0.67 | -$0.42 |
| Q3 2021 | -$0.45 | -$0.09 |
NTRB lost $0.57 per share over the past year, a smaller loss than the year before.
NTRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $437.5K | -30% |
| Q2 2026 | $433.4K | -35% |
| Q1 2026 | $400.7K | -38% |
| Q4 2025 | $346.1K | -46% |
| Q3 2025 | $622.5K | +41% |
| Q2 2025 | $667.4K | +63% |
| Q1 2025 | $642.4K | +22% |
| Q4 2024 | $645.8K | +51% |
NTRB's revenue has slid since its 2025 peak: $437,514 last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -204% | +118 points |
| Q2 2026 | -289% | -78 points |
| Q1 2026 | -255% | +611 points |
| Q4 2025 | -1121% | -900 points |
| Q3 2025 | -322% | -3.5 points |
| Q2 2025 | -212% | +251 points |
| Q1 2025 | -865% | -616 points |
| Q4 2024 | -221% | +182 points |
NTRB's operating margin was −204% last quarter, up 118 points from the same quarter a year ago.
NTRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$731.8K | +$507.4K |
| Q4 2025 | -$1.8M | -$695.9K |
| Q3 2025 | -$1.3M | +$269.3K |
| Q2 2025 | -$1.3M | -$502.2K |
| Q1 2025 | -$1.2M | -$471.9K |
| Q4 2024 | -$1.1M | +$7.7K |
| Q3 2024 | -$1.6M | -$587.5K |
| Q2 2024 | -$840.1K | -$87.6K |
NTRB has burned cash in almost every quarter: −$5M over the past year, against −$5M the year before.
NTRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +9.3% | +1M shares |
| 3 years | +44% | +3.7M shares |
| 5 years | +84% | +5.6M shares |
| Available history | +92% | +5.8M shares |
NTRB has 12M diluted shares, up 9.3% from a year ago.
NTRB Net Leverage
NTRB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NTRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 48.5 | Neutral |
NTRB's weekly RSI is 55 (neutral) and its Stochastic is 48 (neutral).
NTRB PE vs Healthcare Sector
NTRB has no meaningful PE right now: it lost money over the past year.
NTRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.47 | 7.7% below |
| 20 week MA | $5.16 | 16% above |
| 50 week MA | $4.51 | 32% above |
| 100 week MA | $5.54 | 7.8% above |
| 200 week MA | $4.69 | 27% above |
NTRB's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
NTRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $5.74 | $3.10 | -46% |
| 2022 | $3.10 | $3.59 | +16% |
| 2023 | $3.59 | $2.32 | -35% |
| 2024 | $2.32 | $3.85 | +66% |
| 2025 | $3.85 | $4.80 | +25% |
| 2026 YTD | $4.80 | $5.97 | +24% |
NTRB has finished higher in three of the last five years. It's up 24% so far in 2026.